-
1
-
-
53749096863
-
10-year follow-up of intensive glucose control in type 2 diabetes
-
Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-1589.
-
(2008)
N Engl J Med
, vol.359
, pp. 1577-1589
-
-
Holman, R.R.1
Paul, S.K.2
Bethel, M.A.3
Matthews, D.R.4
Neil, H.A.5
-
2
-
-
65349085059
-
Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005
-
Preis SR, Hwang SJ, Coady S, Pencina MJ, D'Agostino RB Sr, Savage PJ, Levy D, Fox CS. Trends in all-cause and cardiovascular disease mortality among women and men with and without diabetes mellitus in the Framingham Heart Study, 1950 to 2005. Circulation 2009;119:1728-1735.
-
(2009)
Circulation
, vol.119
, pp. 1728-1735
-
-
Preis, S.R.1
Hwang, S.J.2
Coady, S.3
Pencina, M.J.4
D'Agostino Sr., R.B.5
Savage, P.J.6
Levy, D.7
Fox, C.S.8
-
3
-
-
34247483998
-
Increasing cardiovascular disease burden due to diabetes mellitus: The Framingham Heart Study
-
DOI 10.1161/CIRCULATIONAHA.106.658948
-
Fox CS, Coady S, Sorlie PD, D'Agostino RB Sr, Pencina MJ, Vasan RS, Meigs JB, Levy D, Savage PJ. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study. Circulation 2007;115:1544-1550. (Pubitemid 46648639)
-
(2007)
Circulation
, vol.115
, Issue.12
, pp. 1544-1550
-
-
Fox, C.S.1
Coady, S.2
Sorlie, P.D.3
D'Agostino Sr., R.B.4
Pencina, M.J.5
Vasan, R.S.6
Meigs, J.B.7
Levy, D.8
Savage, P.J.9
-
4
-
-
77953821528
-
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies
-
Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M, Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215-2222.
-
(2010)
Lancet
, vol.375
, pp. 2215-2222
-
-
Sarwar, N.1
Gao, P.2
Seshasai, S.R.3
Gobin, R.4
Kaptoge, S.5
Di Angelantonio, E.6
Ingelsson, E.7
Lawlor, D.A.8
Selvin, E.9
Stampfer, M.10
Stehouwer, C.D.11
Lewington, S.12
Pennells, L.13
Thompson, A.14
Sattar, N.15
White, I.R.16
Ray, K.K.17
Danesh, J.18
-
5
-
-
0034641568
-
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
-
Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000;321:405-412. (Pubitemid 30609442)
-
(2000)
British Medical Journal
, vol.321
, Issue.7258
, pp. 405-412
-
-
Stratton, I.M.1
Adler, A.I.2
Neil, H.A.W.3
Matthews, D.R.4
Manley, S.E.5
Cull, C.A.6
Hadden, D.7
Turner, R.C.8
Holman, R.R.9
-
6
-
-
0027406191
-
Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the multiple risk factor intervention trial
-
Stamler J, Vaccaro O, Neaton JD,Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993;16:434-444. (Pubitemid 23046633)
-
(1993)
Diabetes Care
, vol.16
, Issue.2
, pp. 434-444
-
-
Stamler, J.1
Vaccaro, O.2
Neaton, J.D.3
Wentworth, D.4
-
7
-
-
0034641550
-
Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study
-
Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA, Wright AD, Turner RC, Holman RR. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. Br Med J 2000;321:412-419. (Pubitemid 30609443)
-
(2000)
British Medical Journal
, vol.321
, Issue.7258
, pp. 412-419
-
-
Adler, A.I.1
Stratton, I.M.2
Neil, H.A.W.3
Yudkin, J.S.4
Matthews, D.R.5
Cull, C.A.6
Wright, A.D.7
Turner, R.C.8
Holman, R.R.9
-
8
-
-
45149131667
-
Effects of intensive glucose lowering in type 2 diabetes
-
DOI 10.1056/NEJMoa0802743
-
Gerstein HC, Miller ME, Byington RP, Goff DC Jr, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm RH Jr, Probstfield JL, Simons-Morton DG, Friedewald WT. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-2559. (Pubitemid 351831356)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.24
, pp. 2545-2559
-
-
Friedewald, W.T.1
Buse, J.B.2
Bigger, J.T.3
Byington, R.P.4
Cushman, W.C.5
Gerstein, H.C.6
Ginsberg, H.N.7
Goff Jr., D.C.8
Grimm Jr., R.H.9
Ismail-Beigi, F.10
Probstfield, J.L.11
Simons-Morton, D.G.12
-
9
-
-
45149133036
-
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
-
DOI 10.1056/NEJMoa0802987
-
Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, Marre M, Cooper M, Glasziou P, Grobbee D, Hamet P, Harrap S, Heller S, Liu L, Mancia G, Mogensen CE, Pan C, Poulter N, Rodgers A, Williams B, Bompoint S, de Galan BE, Joshi R, Travert F. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008; 358:2560-2572. (Pubitemid 351831357)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.24
, pp. 2560-2572
-
-
Patel, A.1
MacMahon, S.2
Chalmers, J.3
Neal, B.4
Billot, L.5
Woodward, M.6
Marre, M.7
Cooper, M.8
Glasziou, P.9
Grobbee, D.10
Hamet, P.11
Harrap, S.12
Heller, S.13
Liu, L.14
Mancia, G.15
Mogensen, C.E.16
Pan, C.17
Poulter, N.18
Rodgers, A.19
Williams, B.20
Bompoint, S.21
De Galan, B.E.22
Joshi, R.23
Travert, F.24
more..
-
10
-
-
58149389215
-
Glucose control and vascular complications in veterans with type 2 diabetes
-
Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, Zieve FJ, Marks J, Davis SN, Hayward R, Warren SR, Goldman S, McCarren M, Vitek ME, Henderson WG, Huang GD. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-139.
-
(2009)
N Engl J Med
, vol.360
, pp. 129-139
-
-
Duckworth, W.1
Abraira, C.2
Moritz, T.3
Reda, D.4
Emanuele, N.5
Reaven, P.D.6
Zieve, F.J.7
Marks, J.8
Davis, S.N.9
Hayward, R.10
Warren, S.R.11
Goldman, S.12
McCarren, M.13
Vitek, M.E.14
Henderson, W.G.15
Huang, G.D.16
-
11
-
-
33846414720
-
Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: Executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)
-
DOI 10.1093/eurheartj/ehl260
-
Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28:88-136. (Pubitemid 46137814)
-
(2007)
European Heart Journal
, vol.28
, Issue.1
, pp. 88-136
-
-
Ryden, L.1
Standl, E.2
Malgorzata, B.3
Van Den Berghe, G.4
Betteridge, J.5
De Boer, M.-J.6
Cosentino, F.7
Jonsson, B.8
Laakso, M.9
Malmberg, K.10
Priori, S.11
Ostergren, J.12
Tuomilehto, J.13
Thrainsdottir, I.14
Vanhorebeek, I.15
Stramba-Badiale, M.16
Lindgren, P.17
Qiao, Q.18
Blanc, J.-J.19
Budaj, A.20
Camm, J.21
Dean, V.22
Deckers, J.23
Dickstein, K.24
Lekakis, J.25
McGregor, K.26
Metra, M.27
Morais, J.28
Osterspey, A.29
Tamargo, J.30
Zamorano, J.L.31
Deckers, J.W.32
Bertrand, M.33
Charbonnel, B.34
Erdmann, E.35
Ferrannini, E.36
Flyvbjerg, A.37
Gohlke, H.38
Juanatey, J.R.G.39
Graham, I.40
Monteiro, P.F.41
Parhofer, K.42
Pyorala, K.43
Raz, I.44
Schernthaner, G.45
Volpe, M.46
Wood, D.47
more..
-
12
-
-
35148892823
-
European guidelines on cardiovascular disease prevention in clinical practice: Executive summary
-
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen ML, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schneiderman N, Stalenhoef AF, Tokgozoglu L, Wiklund O, Zampelas A. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007;28:2375-2414.
-
(2007)
Eur Heart J
, vol.28
, pp. 2375-2414
-
-
Graham, I.1
Atar, D.2
Borch-Johnsen, K.3
Boysen, G.4
Burell, G.5
Cifkova, R.6
Dallongeville, J.7
De Backer, G.8
Ebrahim, S.9
Gjelsvik, B.10
Herrmann-Lingen, C.11
Hoes, A.12
Humphries, S.13
Knapton, M.14
Perk, J.15
Priori, S.G.16
Pyorala, K.17
Reiner, Z.18
Ruilope, L.19
Sans-Menendez, S.20
Scholte Op Reimer, W.21
Weissberg, P.22
Wood, D.23
Yarnell, J.24
Zamorano, J.L.25
Walma, E.26
Fitzgerald, T.27
Cooney, M.T.28
Dudina, A.29
Vahanian, A.30
Camm, J.31
De Caterina, R.32
Dean, V.33
Dickstein, K.34
Funck-Brentano, C.35
Filippatos, G.36
Hellemans, I.37
Kristensen, S.D.38
McGregor, K.39
Sechtem, U.40
Silber, S.41
Tendera, M.42
Widimsky, P.43
Altiner, A.44
Bonora, E.45
Durrington, P.N.46
Fagard, R.47
Giampaoli, S.48
Hemingway, H.49
Hakansson, J.50
Kjeldsen, S.E.51
Larsen, M.L.52
Mancia, G.53
Manolis, A.J.54
Orth-Gomer, K.55
Pedersen, T.56
Rayner, M.57
Ryden, L.58
Sammut, M.59
Schneiderman, N.60
Stalenhoef, A.F.61
Tokgozoglu, L.62
Wiklund, O.63
Zampelas, A.64
more..
-
13
-
-
34547615709
-
The task force for the management of arterial hypertension of the European Society of Hypertension, the task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension
-
The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
-
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Manolis A, Nilsson PM, Redon J, Struijker-Boudier HA, Viigimaa M, Adamopoulos S, Bertomeu V, Clement D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, O'Brien E, Ponikowski P, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B, The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-1536.
-
(2007)
Eur Heart J
, vol.28
, pp. 1462-1536
-
-
Mancia, G.1
De Backer, G.2
Dominiczak, A.3
Cifkova, R.4
Fagard, R.5
Germano, G.6
Grassi, G.7
Heagerty, A.M.8
Kjeldsen, S.E.9
Laurent, S.10
Narkiewicz, K.11
Ruilope, L.12
Rynkiewicz, A.13
Schmieder, R.E.14
Struijker Boudier, H.A.15
Zanchetti, A.16
Vahanian, A.17
Camm, J.18
De Caterina, R.19
Dean, V.20
Dickstein, K.21
Filippatos, G.22
Funck-Brentano, C.23
Hellemans, I.24
Kristensen, S.D.25
McGregor, K.26
Sechtem, U.27
Silber, S.28
Tendera, M.29
Widimsky, P.30
Zamorano, J.L.31
Erdine, S.32
Kiowski, W.33
Agabiti-Rosei, E.34
Ambrosioni, E.35
Lindholm, L.H.36
Manolis, A.37
Nilsson, P.M.38
Redon, J.39
Struijker-Boudier, H.A.40
Viigimaa, M.41
Adamopoulos, S.42
Bertomeu, V.43
Clement, D.44
Farsang, C.45
Gaita, D.46
Lip, G.47
Mallion, J.M.48
Manolis, A.J.49
O'Brien, E.50
Ponikowski, P.51
Ruschitzka, F.52
Tamargo, J.53
Van Zwieten, P.54
Waeber, B.55
Williams, B.56
more..
-
14
-
-
69149095761
-
ESH/ESC Guidelines for the management of hypertension, from theory to practice: Global cardiovascular risk concept
-
Volpe M, Tocci G. 2007 ESH/ESC Guidelines for the management of hypertension, from theory to practice: global cardiovascular risk concept. J Hypertens Suppl 2009;27:S3-S11.
-
(2007)
J Hypertens Suppl 2009
, vol.27
-
-
Volpe, M.1
Tocci, G.2
-
15
-
-
33744828023
-
Global Guideline for Type 2 Diabetes: Recommendations for standard, comprehensive, and minimal care
-
IDF Clinical Guidelines Task Force
-
IDF Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes: recommendations for standard, comprehensive, and minimal care. Diabet Med 2006;23:579-593.
-
(2006)
Diabet Med
, vol.23
, pp. 579-593
-
-
-
16
-
-
0038460302
-
The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report
-
DOI 10.1001/jama.289.19.2560
-
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-2572. (Pubitemid 37430158)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.19
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright Jr., J.T.10
Roccella, E.J.11
-
17
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
DOI 10.1161/01.CIR.0000133317.49796.0E
-
Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, Pasternak RC, Smith SC Jr, Stone NJ. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-239. (Pubitemid 38924592)
-
(2004)
Circulation
, vol.110
, Issue.2
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Bairey Merz, C.N.3
Brewer Jr., H.B.4
Clark, L.T.5
Hunninghake, D.B.6
Pasternak, R.C.7
Smith Jr., S.C.8
Stone, N.J.9
-
18
-
-
58149301489
-
Intensive glycemic control and the prevention of cardiovascular events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association
-
Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P, Gale EA, Howard BV, Kirkman MS, Kosiborod M, Reaven P, Sherwin RS. Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association. J Am Coll Cardiol 2009;53: 298-304.
-
(2009)
J Am Coll Cardiol
, vol.53
, pp. 298-304
-
-
Skyler, J.S.1
Bergenstal, R.2
Bonow, R.O.3
Buse, J.4
Deedwania, P.5
Gale, E.A.6
Howard, B.V.7
Kirkman, M.S.8
Kosiborod, M.9
Reaven, P.10
Sherwin, R.S.11
-
19
-
-
75149180515
-
Standards of medical care in diabetes-2010
-
Diabetes Association
-
Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl 1):S11-S61.
-
(2010)
Diabetes Care
, vol.33
, Issue.SUPPL. 1
-
-
-
20
-
-
33846083971
-
Primary prevention of cardiovascular diseases in people with diabetes mellitus: A scientific statement from the American Heart Association and the American Diabetes Association
-
DOI 10.1161/CIRCULATIONAHA.106.179294, PII 0000301720070102000018
-
Buse JB, Ginsberg HN, Bakris GL, Clark NG, Costa F, Eckel R, Fonseca V, Gerstein HC, Grundy S, Nesto RW, Pignone MP, Plutzky J, Porte D, Redberg R, Stitzel KF, Stone NJ. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2007;115: 114-126. (Pubitemid 46058619)
-
(2007)
Circulation
, vol.115
, Issue.1
, pp. 114-126
-
-
Buse, J.B.1
Ginsberg, H.N.2
Bakris, G.L.3
Clark, N.G.4
Costa, F.5
Eckel, R.6
Fonseca, V.7
Gerstein, H.C.8
Grundy, S.9
Nesto, R.W.10
Pignone, M.P.11
Plutzky, J.12
Porte, D.13
Redberg, R.14
Stitzel, K.F.15
Stone, N.J.16
-
21
-
-
33644810298
-
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
-
British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association
-
British Cardiac Society; British Hypertension Society; Diabetes UK; HEART UK; Primary Care Cardiovascular Society; Stroke Association. JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart 2005;91(Suppl 5):v1-v52.
-
(2005)
Heart
, vol.91
, Issue.SUPPL. 5
-
-
-
23
-
-
77952304299
-
The 2010 canadian hypertension education program recommendations for the management of hypertension: Part 2-therapy
-
Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, Quinn RR, Mahon JL, Herman RJ, Schiffrin EL, Ruzicka M, Larochelle P, Feldman RD, Lebel M, Poirier L, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallee M, Prasad GV, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Tobe SW. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2-therapy. Can J Cardiol 2010;26:249-258.
-
(2010)
Can J Cardiol
, vol.26
, pp. 249-258
-
-
Hackam, D.G.1
Khan, N.A.2
Hemmelgarn, B.R.3
Rabkin, S.W.4
Touyz, R.M.5
Campbell, N.R.6
Padwal, R.7
Campbell, T.S.8
Lindsay, M.P.9
Hill, M.D.10
Quinn, R.R.11
Mahon, J.L.12
Herman, R.J.13
Schiffrin, E.L.14
Ruzicka, M.15
Larochelle, P.16
Feldman, R.D.17
Lebel, M.18
Poirier, L.19
Arnold, J.M.20
Moe, G.W.21
Howlett, J.G.22
Trudeau, L.23
Bacon, S.L.24
Petrella, R.J.25
Milot, A.26
Stone, J.A.27
Drouin, D.28
Boulanger, J.M.29
Sharma, M.30
Hamet, P.31
Fodor, G.32
Dresser, G.K.33
Carruthers, S.G.34
Pylypchuk, G.35
Burgess, E.D.36
Burns, K.D.37
Vallee, M.38
Prasad, G.V.39
Gilbert, R.E.40
Leiter, L.A.41
Jones, C.42
Ogilvie, R.I.43
Woo, V.44
McFarlane, P.A.45
Hegele, R.A.46
Tobe, S.W.47
more..
-
24
-
-
77952310384
-
Position statement of the Australian Diabetes Society: Individualisation of glycated haemoglobin targets for adults with diabetes mellitus
-
Cheung NW, Conn JJ, d'Emden MC, Gunton JE, Jenkins AJ, Ross GP, Sinha AK, Andrikopoulos S, Colagiuri S, Twigg SM. Position statement of the Australian Diabetes Society: individualisation of glycated haemoglobin targets for adults with diabetes mellitus. Med J Aust 2009;191:339-344.
-
(2009)
Med J Aust
, vol.191
, pp. 339-344
-
-
Cheung, N.W.1
Conn, J.J.2
D'Emden, M.C.3
Gunton, J.E.4
Jenkins, A.J.5
Ross, G.P.6
Sinha, A.K.7
Andrikopoulos, S.8
Colagiuri, S.9
Twigg, S.M.10
-
25
-
-
0037079309
-
Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
-
DOI 10.1016/S0140-6736(02)11911-8
-
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913. (Pubitemid 35472129)
-
(2002)
Lancet
, vol.360
, Issue.9349
, pp. 1903-1913
-
-
Lewington, S.1
Clarke, R.2
Qizilbash, N.3
Peto, R.4
Collins, R.5
-
26
-
-
0032511580
-
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
-
United Kingdom Prospective Diabetes Study Group
-
United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713.
-
(1998)
BMJ
, vol.317
, pp. 703-713
-
-
-
27
-
-
0032511601
-
Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
-
United Kingdom Prospective Diabetes Study Group
-
United Kingdom Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ 1998;317:713-720.
-
(1998)
BMJ
, vol.317
, pp. 713-720
-
-
-
28
-
-
0034074955
-
Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes
-
Estacio RO, Jeffers BW, Gifford N, Schrier RW. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes. Diabetes Care 2000;23(Suppl 2):B54-B64. (Pubitemid 30185779)
-
(2000)
Diabetes Care
, vol.23
, Issue.SUPPL. 2
-
-
Estacio, R.O.1
Jeffers, B.W.2
Gifford, N.3
Schrier, R.W.4
-
29
-
-
0036190137
-
Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes
-
DOI 10.1046/j.1523-1755.2002.00213.x
-
Schrier RW, Estacio RO, Esler A, Mehler P. Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes. Kidney Int 2002;61:1086-1097. (Pubitemid 34175478)
-
(2002)
Kidney International
, vol.61
, Issue.3
, pp. 1086-1097
-
-
Schrier, R.W.1
Estacio, R.O.2
Esler, A.3
Mehler, P.4
-
30
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
DOI 10.1016/S0140-6736(98)04311-6
-
Hansson L, Zanchetti A, Carruthers SG, Dahlof B, Elmfeldt D, Julius S, Menard J, Rahn KH, Wedel H, Westerling S. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 1998;351:1755-1762. (Pubitemid 28269185)
-
(1998)
Lancet
, vol.351
, Issue.9118
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
Dahlof, B.4
Elmfeldt, D.5
Julius, S.6
Menard, J.7
Rahn, K.H.8
Wedel, H.9
Westerling, S.10
-
31
-
-
0038708274
-
Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: Does a J-shaped curve exist in smokers?
-
DOI 10.1097/00004872-200304000-00024
-
Zanchetti A, Hansson L, Clement D, Elmfeldt D, Julius S, Rosenthal T, Waeber B, Wedel H. Benefits and risks of more intensive blood pressure lowering in hypertensive patients of the HOT study with different risk profiles: does a J-shaped curve exist in smokers? J Hypertens 2003;21:797-804. (Pubitemid 36549676)
-
(2003)
Journal of Hypertension
, vol.21
, Issue.4
, pp. 797-804
-
-
Zanchetti, A.1
Hansson, L.2
Clement, D.3
Elmfeldt, D.4
Julius, S.5
Rosenthal, T.6
Waeber, B.7
Wedel, H.8
-
32
-
-
77951735232
-
Effects of intensive blood-pressure control in type 2 diabetes mellitus
-
Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, Simons-Morton DG, Basile JN, Corson MA, Probstfield JL, Katz L, Peterson KA, Friedewald WT, Buse JB, Bigger JT, Gerstein HC, Ismail-Beigi F. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362: 1575-1585.
-
(2010)
N Engl J Med
, vol.362
, pp. 1575-1585
-
-
Cushman, W.C.1
Evans, G.W.2
Byington, R.P.3
Goff Jr., D.C.4
Grimm Jr., R.H.5
Cutler, J.A.6
Simons-Morton, D.G.7
Basile, J.N.8
Corson, M.A.9
Probstfield, J.L.10
Katz, L.11
Peterson, K.A.12
Friedewald, W.T.13
Buse, J.B.14
Bigger, J.T.15
Gerstein, H.C.16
Ismail-Beigi, F.17
-
33
-
-
10544229794
-
Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension
-
DOI 10.1001/jama.276.23.1886
-
Curb JD, Pressel SL, Cutler JA, Savage PJ, Applegate WB, Black H, Camel G, Davis BR, Frost PH, Gonzalez N, Guthrie G, Oberman A, Rutan GH, Stamler J. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996;276: 1886-1892. (Pubitemid 26419185)
-
(1996)
Journal of the American Medical Association
, vol.276
, Issue.23
, pp. 1886-1892
-
-
Curb, J.D.1
Pressel, S.L.2
Cutler, J.A.3
Savage, P.J.4
Applegate, W.B.5
Black, H.6
Camel, G.7
Davis, B.R.8
Frost, P.H.9
Gonzalez, N.10
Guthrie, G.11
Oberman, A.12
Rutan, G.H.13
Stamler, J.14
-
34
-
-
0033522149
-
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension
-
DOI 10.1056/NEJM199903043400902
-
Tuomilehto J, Rastenyte D, Birkenhager WH, Thijs L, Antikainen R, Bulpitt CJ, Fletcher AE, Forette F, Goldhaber A, Palatini P, Sarti C, Fagard R. Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med 1999; 340:677-684. (Pubitemid 29110751)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.9
, pp. 677-684
-
-
Tuomilehto, J.1
Rastenyte, D.2
Birkenhager, W.H.3
Thijs, L.4
Antikainen, R.5
Bulpitt, C.J.6
Fletcher, A.E.7
Forette, F.8
Goldhaber, A.9
Palatini, P.10
Sarti, C.11
Fagard, R.12
Staessen, J.A.13
-
35
-
-
0034700790
-
Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
-
Heart Outcomes Prevention Evaluation Study Investigators
-
Heart Outcomes Prevention Evaluation Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355: 253-259.
-
(2000)
Lancet
, vol.355
, pp. 253-259
-
-
-
36
-
-
0035922447
-
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes
-
Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, Ritz E, Atkins RC, Rohde R, Raz I. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med 2001; 345:851-860.
-
(2001)
N Engl J Med
, vol.345
, pp. 851-860
-
-
Lewis, E.J.1
Hunsicker, L.G.2
Clarke, W.R.3
Berl, T.4
Pohl, M.A.5
Lewis, J.B.6
Ritz, E.7
Atkins, R.C.8
Rohde, R.9
Raz, I.10
-
37
-
-
0035922441
-
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy
-
Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, Remuzzi G, Snapinn SM, Zhang Z, Shahinfar S. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 2001;345:861-869.
-
(2001)
N Engl J Med
, vol.345
, pp. 861-869
-
-
Brenner, B.M.1
Cooper, M.E.2
De Zeeuw, D.3
Keane, W.F.4
Mitch, W.E.5
Parving, H.H.6
Remuzzi, G.7
Snapinn, S.M.8
Zhang, Z.9
Shahinfar, S.10
-
38
-
-
0035922444
-
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
-
Parving HH, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med 2001;345:870-878.
-
(2001)
N Engl J Med
, vol.345
, pp. 870-878
-
-
Parving, H.H.1
Lehnert, H.2
Brochner-Mortensen, J.3
Gomis, R.4
Andersen, S.5
Arner, P.6
-
39
-
-
11144356866
-
Reductions in the risks of recurrent stroke in patients with and without diabetes: The PROGRESS Trial
-
DOI 10.1080/08037050410029605
-
Berthet K, Neal BC, Chalmers JP, MacMahon SW, Bousser MG, Colman SA, Woodward M. Reductions in the risks of recurrent stroke in patients with and without diabetes: the PROGRESS Trial. Blood Press 2004;13:7-13. (Pubitemid 38455840)
-
(2004)
Blood Pressure
, vol.13
, Issue.1
, pp. 7-13
-
-
Berthet, K.1
Neal, B.C.2
Chalmers, J.P.3
MacMahon, S.W.4
Bousser, M.-G.5
Colman, S.A.6
Woodward, M.7
Anderson, C.8
Cutler, J.9
Davis, S.10
Donnan, G.11
Hansson, L.12
Harrap, S.13
Lees, K.14
Liu, L.15
Mancia, G.16
Neal, B.17
Omae, T.18
Reid, J.19
Rodgers, A.20
Sega, R.21
Terent, A.22
Tzourio, C.23
Warlow, C.24
Anderson, N.25
Bladin, C.26
Chambers, B.27
Gordon, G.28
Sharpe, N.29
Collins, R.30
Sandercock, P.31
Simes, J.32
Sleight, P.33
Colman, S.34
more..
-
40
-
-
27744542905
-
Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial
-
DOI 10.1681/ASN.2004090763
-
Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, Drury PL, Esmatjes E, Hricik D, Pohl M, Raz I, Vanhille P, Wiegmann TB, Wolfe BM, Locatelli F, Goldhaber SZ, Lewis EJ. Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial. J Am Soc Nephrol 2005;16:2170-2179. (Pubitemid 41716450)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.7
, pp. 2170-2179
-
-
Berl, T.1
Hunsicker, L.G.2
Lewis, J.B.3
Pfeffer, M.A.4
Porush, J.G.5
Rouleau, J.-L.6
Drury, P.L.7
Esmatjes, E.8
Hricik, D.9
Pohl, M.10
Raz, I.11
Vanhille, P.12
Wiegmann, T.B.13
Wolfe, B.M.14
Locatelli, F.15
Goldhaber, S.Z.16
Lewis, E.J.17
-
41
-
-
33644912981
-
Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: Clinical implications and limitations
-
DOI 10.1681/ASN.2004110919
-
Pohl MA, Blumenthal S, Cordonnier DJ, De Alvaro F, Deferrari G, Eisner G, Esmatjes E, Gilbert RE, Hunsicker LG, de Faria JB, Mangili R, Moore J Jr, Reisin E, Ritz E, Schernthaner G, Spitalewitz S, Tindall H, Rodby RA, Lewis EJ. Independent and additive impact of blood pressure control and angiotensin II receptor blockade on renal outcomes in the irbesartan diabetic nephropathy trial: clinical implications and limitations. J Am Soc Nephrol 2005;16:3027-3037. (Pubitemid 44743500)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.10
, pp. 3027-3037
-
-
Pohl, M.A.1
Blumenthal, S.2
Cordonnier, D.J.3
De Alvaro, F.4
DeFerrari, G.5
Eisner, G.6
Esmatjes, E.7
Gilbert, R.E.8
Hunsicker, L.G.9
Lopes De Faria, J.B.10
Mangili, R.11
Moore Jr., J.12
Reisin, E.13
Ritz, E.14
Schernthaner, G.15
Spitalewitz, S.16
Tindall, H.17
Rodby, R.A.18
Lewis, E.J.19
-
42
-
-
34548420712
-
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
-
DOI 10.1016/S0140-6736(07)61303-8, PII S0140673607613038
-
Patel A, MacMahon S, Chalmers J, Neal B, Woodward M, Billot L, Harrap S, Poulter N, Marre M, Cooper M, Glasziou P, Grobbee DE, Hamet P, Heller S, Liu LS, Mancia G, Mogensen CE, Pan CY, Rodgers A, Williams B. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007;370:829-840. (Pubitemid 47362321)
-
(2007)
Lancet
, vol.370
, Issue.9590
, pp. 829-840
-
-
Patel, A.1
-
43
-
-
78649875453
-
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease
-
Heerspink HJ, Ninomiya T, Perkovic V, Woodward M, Zoungas S, Cass A, Cooper M, Grobbee DE, Mancia G, Mogensen CE, Neal B, Chalmers J. Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. Eur Heart J 2010;31:2888-2896.
-
(2010)
Eur Heart J
, vol.31
, pp. 2888-2896
-
-
Heerspink, H.J.1
Ninomiya, T.2
Perkovic, V.3
Woodward, M.4
Zoungas, S.5
Cass, A.6
Cooper, M.7
Grobbee, D.E.8
Mancia, G.9
Mogensen, C.E.10
Neal, B.11
Chalmers, J.12
-
44
-
-
67649651744
-
When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal
-
Zanchetti A, Grassi G, Mancia G. When should antihypertensive drug treatment be initiated and to what levels should systolic blood pressure be lowered? A critical reappraisal. J Hypertens 2009;27:923-934.
-
(2009)
J Hypertens
, vol.27
, pp. 923-934
-
-
Zanchetti, A.1
Grassi, G.2
Mancia, G.3
-
45
-
-
77956632368
-
Effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial
-
Mancia G. Effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation 2010;122:847-849.
-
(2010)
Circulation
, vol.122
, pp. 847-849
-
-
Mancia, G.1
-
46
-
-
33745295923
-
Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
-
Messerli FH, Mancia G, Conti CR, Hewkin AC, Kupfer S, Champion A, Kolloch R, Benetos A, Pepine CJ. Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous? Ann Intern Med 2006;144:884-893. (Pubitemid 46768128)
-
(2006)
Annals of Internal Medicine
, vol.144
, Issue.12
, pp. 884-893
-
-
Messerli, F.H.1
Mancia, G.2
Conti, C.R.3
Hewkin, A.C.4
Kupfer, S.5
Champion, A.6
Kolloch, R.7
Benetos, A.8
Pepine, C.J.9
-
47
-
-
70350440515
-
The J-curve between blood pressure and coronary artery disease or essential hypertension: Exactly how essential?
-
Messerli FH, Panjrath GS. The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential? J Am Coll Cardiol 2009;54:1827-1834.
-
(2009)
J Am Coll Cardiol
, vol.54
, pp. 1827-1834
-
-
Messerli, F.H.1
Panjrath, G.S.2
-
48
-
-
34250819387
-
Diastolic blood pressure and mortality in the elderly with cardiovascular disease
-
DOI 10.1161/HYPERTENSIONAHA.107.089797, PII 0000426820070700000041
-
Protogerou AD, Safar ME, Iaria P, Safar H, Le Dudal K, Filipovsky J, Henry O, Ducimetiere P, Blacher J. Diastolic blood pressure and mortality in the elderly with cardiovascular disease. Hypertension 2007;50:172-180. (Pubitemid 46986039)
-
(2007)
Hypertension
, vol.50
, Issue.1
, pp. 172-180
-
-
Protogerou, A.D.1
Safar, M.E.2
Iaria, P.3
Safar, H.4
Le Dudal, K.5
Filipovsky, J.6
Henry, O.7
Ducimetiere, P.8
Blacher, J.9
-
49
-
-
73849098313
-
Outcomes among hypertensive patients with concomitant peripheral and coronary artery disease: Findings from the INternational VErapamil-SR/ Trandolapril STudy
-
Bavry AA, Anderson RD, Gong Y, Denardo SJ, Cooper-Dehoff RM, Handberg EM, Pepine CJ. Outcomes Among hypertensive patients with concomitant peripheral and coronary artery disease: findings from the INternational VErapamil-SR/ Trandolapril STudy. Hypertension 2010;55:48-53.
-
(2010)
Hypertension
, vol.55
, pp. 48-53
-
-
Bavry, A.A.1
Anderson, R.D.2
Gong, Y.3
Denardo, S.J.4
Cooper-Dehoff, R.M.5
Handberg, E.M.6
Pepine, C.J.7
-
50
-
-
66849131593
-
Ischemic stroke in South Asians: A review of the epidemiology, pathophysiology, and ethnicity-related clinical features
-
Gunarathne A, Patel JV, Gammon B, Gill PS, Hughes EA, Lip GY. Ischemic stroke in South Asians: a review of the epidemiology, pathophysiology, and ethnicity-related clinical features. Stroke 2009;40:e415-e423.
-
(2009)
Stroke
, vol.40
-
-
Gunarathne, A.1
Patel, J.V.2
Gammon, B.3
Gill, P.S.4
Hughes, E.A.5
Lip, G.Y.6
-
51
-
-
22144477948
-
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: Results of prospectively designed overviews of randomized trials
-
DOI 10.1001/archinte.165.12.1410
-
Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, Woodward M, MacMahon S. Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials. Arch Intern Med 2005; 165:1410-1419. (Pubitemid 40973424)
-
(2005)
Archives of Internal Medicine
, vol.165
, Issue.12
, pp. 1410-1419
-
-
Turnbull, F.1
-
52
-
-
27844563671
-
Antihypertensive therapy in diabetes mellitus: Insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis
-
DOI 10.1038/sj.jhh.1001926, PII 1001926
-
Varughese GI, Lip GY. Antihypertensive therapy in diabetes mellitus: insights from ALLHAT and the Blood Pressure-Lowering Treatment Trialists' Collaboration meta-analysis. J Hum Hypertens 2005;19:851-853. (Pubitemid 41637600)
-
(2005)
Journal of Human Hypertension
, vol.19
, Issue.11
, pp. 851-853
-
-
Varughese, G.I.1
Lip, G.Y.H.2
-
53
-
-
0344373794
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
and Coordinators for the ALLHAT Collaborative Research Group
-
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002;288:2981-2997.
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
Officers, A.1
-
54
-
-
34548392359
-
Vascular outcome in type 2 diabetes: an ADVANCE?
-
DOI 10.1016/S0140-6736(07)61304-X, PII S014067360761304X
-
Kaplan NM. Vascular outcome in type 2 diabetes: an ADVANCE? Lancet 2007; 370:804-805. (Pubitemid 47362322)
-
(2007)
Lancet
, vol.370
, Issue.9590
, pp. 804-805
-
-
Kaplan, N.M.1
-
55
-
-
77957674852
-
Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: An ADVANCE trial-based analysis
-
Glasziou PP, Clarke P, Alexander J, Rajmokan M, Beller E, Woodward M, Chalmers J, Poulter N, Patel A. Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis. Med J Aust 2010;193:320-324.
-
(2010)
Med J Aust
, vol.193
, pp. 320-324
-
-
Glasziou, P.P.1
Clarke, P.2
Alexander, J.3
Rajmokan, M.4
Beller, E.5
Woodward, M.6
Chalmers, J.7
Poulter, N.8
Patel, A.9
-
56
-
-
77952468076
-
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: Results from the ADVANCE trial
-
Ninomiya T, Zoungas S, Neal B, Woodward M, Patel A, Perkovic V, Cass A, Cooper M, Grobbee D, Hamet P, Harrap S, Liu L, Mancia G, Mogensen CE, Poulter N, Rodgers A, Williams B, MacMahon S, Chalmers J. Efficacy and safety of routine blood pressure lowering in older patients with diabetes: results from the ADVANCE trial. J Hypertens 2010;28:1141-1149.
-
(2010)
J Hypertens
, vol.28
, pp. 1141-1149
-
-
Ninomiya, T.1
Zoungas, S.2
Neal, B.3
Woodward, M.4
Patel, A.5
Perkovic, V.6
Cass, A.7
Cooper, M.8
Grobbee, D.9
Hamet, P.10
Harrap, S.11
Liu, L.12
Mancia, G.13
Mogensen, C.E.14
Poulter, N.15
Rodgers, A.16
Williams, B.17
MacMahon, S.18
Chalmers, J.19
-
57
-
-
78649875453
-
Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease
-
Heerspink HJ, Ninomiya T, Perkovic V, Woodward M, Zoungas S, Cass A, Cooper M, Grobbee DE, Mancia G, Mogensen CE, Neal B, Chalmers J. Effects of a fixed combination of perindopril and indapamide in patients with type 2 diabetes and chronic kidney disease. Eur Heart J 2010;31:2888-2896.
-
(2010)
Eur Heart J
, vol.31
, pp. 2888-2896
-
-
Heerspink, H.J.1
Ninomiya, T.2
Perkovic, V.3
Woodward, M.4
Zoungas, S.5
Cass, A.6
Cooper, M.7
Grobbee, D.E.8
Mancia, G.9
Mogensen, C.E.10
Neal, B.11
Chalmers, J.12
-
58
-
-
77951453096
-
Effect of valsartan on the incidence of diabetes and cardiovascular events
-
McMurray JJ, Holman RR, Haffner SM, Bethel MA, Holzhauer B, Hua TA, Belenkov Y, Boolell M, Buse JB, Buckley BM, Chacra AR, Chiang FT, Charbonnel B, Chow CC, Davies MJ, Deedwania P, Diem P, Einhorn D, Fonseca V, Fulcher GR, Gaciong Z, Gaztambide S, Giles T, Horton E, Ilkova H, Jenssen T, Kahn SE, Krum H, Laakso H, Leiter LA, Levitt NS, Mareev V, Martinez F, Masson C, Mazzone T, Meaney E, Nesto R, Pan C, Prager R, Raptis SA, Rutten GE, Sandstroem H, Schaper F, Scheen A, Schmitz O, Sinay I, Soska V, Stender S, Tamas G, Tognoni G, Tuomilehto J, Villamil AS, Vozar J, Califf RM. Effect of valsartan on the incidence of diabetes and cardiovascular events. N Engl J Med 2010;362:1477-1490.
-
(2010)
N Engl J Med
, vol.362
, pp. 1477-1490
-
-
McMurray, J.J.1
Holman, R.R.2
Haffner, S.M.3
Bethel, M.A.4
Holzhauer, B.5
Hua, T.A.6
Belenkov, Y.7
Boolell, M.8
Buse, J.B.9
Buckley, B.M.10
Chacra, A.R.11
Chiang, F.T.12
Charbonnel, B.13
Chow, C.C.14
Davies, M.J.15
Deedwania, P.16
Diem, P.17
Einhorn, D.18
Fonseca, V.19
Fulcher, G.R.20
Gaciong, Z.21
Gaztambide, S.22
Giles, T.23
Horton, E.24
Ilkova, H.25
Jenssen, T.26
Kahn, S.E.27
Krum, H.28
Laakso, H.29
Leiter, L.A.30
Levitt, N.S.31
Mareev, V.32
Martinez, F.33
Masson, C.34
Mazzone, T.35
Meaney, E.36
Nesto, R.37
Pan, C.38
Prager, R.39
Raptis, S.A.40
Rutten, G.E.41
Sandstroem, H.42
Schaper, F.43
Scheen, A.44
Schmitz, O.45
Sinay, I.46
Soska, V.47
Stender, S.48
Tamas, G.49
Tognoni, G.50
Tuomilehto, J.51
Villamil, A.S.52
Vozar, J.53
Califf, R.M.54
more..
-
59
-
-
0034732256
-
Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus
-
DOI 10.1056/NEJM200003303421301
-
Gress TW, Nieto FJ, Shahar E, Wofford MR, Brancati FL. Hypertension and antihypertensive therapy as risk factors for type 2 diabetes mellitus. Atherosclerosis Risk in Communities Study. N Engl J Med 2000;342:905-912. (Pubitemid 30177050)
-
(2000)
New England Journal of Medicine
, vol.342
, Issue.13
, pp. 905-912
-
-
Gress, T.W.1
Nieto, F.J.2
Shahar, E.3
Wofford, M.R.4
Brancati, F.L.5
-
60
-
-
77950511412
-
Executive summary: Standards of medical care in diabetes-2010
-
American Diabetes Association
-
American Diabetes Association. Executive summary: standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl 1):S4-S10.
-
(2010)
Diabetes Care
, vol.33
, Issue.SUPPL. 1
-
-
-
61
-
-
0029147687
-
Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
-
Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-117.
-
(1995)
Diabetes Res Clin Pract
, vol.28
, pp. 103-117
-
-
Ohkubo, Y.1
Kishikawa, H.2
Araki, E.3
Miyata, T.4
Isami, S.5
Motoyoshi, S.6
Kojima, Y.7
Furuyoshi, N.8
Shichiri, M.9
-
62
-
-
0032511583
-
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
-
United Kingdom Prospective Diabetes Study Group
-
United Kingdom Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
-
(1998)
Lancet
, vol.352
, pp. 837-853
-
-
-
63
-
-
0031018291
-
Cardiovascular events and correlates in the Veterans Affairs diabetes feasibility trial: Veterans Affairs cooperative study on glycemic control and complications in type II diabetes
-
Abraira C, Colwell J, Nuttall F, Sawin CT, Henderson W, Comstock JP, Emanuele NV, Levin SR, Pacold I, Lee HS. Cardiovascular events and correlates in the Veterans Affairs Diabetes Feasibility Trial. Veterans Affairs Cooperative Study on Glycemic Control and Complications in Type II Diabetes. Arch Intern Med 1997;157:181-188. (Pubitemid 27058152)
-
(1997)
Archives of Internal Medicine
, vol.157
, Issue.2
, pp. 181-188
-
-
Abraira, C.1
Colwell, J.2
Nuttall, F.3
Sawin, C.T.4
Henderson, W.5
Comstock, J.P.6
Emanuele, N.V.7
Levin, S.R.8
Pacold, I.9
Lee, H.S.10
-
64
-
-
0014914649
-
A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results
-
Meinert CL, Knatterud GL, Prout TE, Klimt CR. A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970;19(suppl):789-830.
-
(1970)
Diabetes
, vol.19
, Issue.SUPPL.
, pp. 789-830
-
-
Meinert, C.L.1
Knatterud, G.L.2
Prout, T.E.3
Klimt, C.R.4
-
65
-
-
0032511566
-
Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)
-
United Kingdom Prospective Diabetes Study Group
-
United Kingdom Prospective Diabetes Study Group. Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854-865.
-
(1998)
Lancet
, vol.352
, pp. 854-865
-
-
-
66
-
-
74949117631
-
The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: Retrospective epidemiological analysis of the ACCORD study
-
Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, Dudl RJ, Ismail-Beigi F, Kimel AR, Hoogwerf B, Horowitz KR, Savage PJ, Seaquist ER, Simmons DL, Sivitz WI, Speril-Hillen JM, Sweeney ME. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ 2010;340: b4909.
-
(2010)
BMJ
, vol.340
-
-
Bonds, D.E.1
Miller, M.E.2
Bergenstal, R.M.3
Buse, J.B.4
Byington, R.P.5
Cutler, J.A.6
Dudl, R.J.7
Ismail-Beigi, F.8
Kimel, A.R.9
Hoogwerf, B.10
Horowitz, K.R.11
Savage, P.J.12
Seaquist, E.R.13
Simmons, D.L.14
Sivitz, W.I.15
Speril-Hillen, J.M.16
Sweeney, M.E.17
-
67
-
-
74949138626
-
The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: Post hoc epidemiological analysis of the ACCORD study
-
Miller ME, Bonds DE, Gerstein HC, Seaquist ER, Bergenstal RM, Calles-Escandon J, Childress RD, Craven TE, Cuddihy RM, Dailey G, Feinglos MN, Ismail-Beigi F, Largay JF, O'Connor PJ, Paul T, Savage PJ, Schubart UK, Sood A, Genuth S. The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. BMJ 2010;340:b5444.
-
(2010)
BMJ
, vol.340
-
-
Miller, M.E.1
Bonds, D.E.2
Gerstein, H.C.3
Seaquist, E.R.4
Bergenstal, R.M.5
Calles-Escandon, J.6
Childress, R.D.7
Craven, T.E.8
Cuddihy, R.M.9
Dailey, G.10
Feinglos, M.N.11
Ismail-Beigi, F.12
Largay, J.F.13
O'Connor, P.J.14
Paul, T.15
Savage, P.J.16
Schubart, U.K.17
Sood, A.18
Genuth, S.19
-
68
-
-
77954159481
-
Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial
-
Riddle MC, Ambrosius WT, Brillon DJ, Buse JB, Byington RP, Cohen RM, Goff DC Jr, Malozowski S, Margolis KL, Probstfield JL, Schnall A, Seaquist ER. Epidemiologic relationships between A1C and all-cause mortality during a median 3.4-year follow-up of glycemic treatment in the ACCORD trial. Diabetes Care 2010;33: 983-990.
-
(2010)
Diabetes Care
, vol.33
, pp. 983-990
-
-
Riddle, M.C.1
Ambrosius, W.T.2
Brillon, D.J.3
Buse, J.B.4
Byington, R.P.5
Cohen, R.M.6
Goff Jr., D.C.7
Malozowski, S.8
Margolis, K.L.9
Probstfield, J.L.10
Schnall, A.11
Seaquist, E.R.12
-
69
-
-
80052873231
-
Oral presentation: Update on epidemiologic research to explain the higher mortality in the intensive glycaemic control arm of the ACCORD trial. Interest group discussion on epidemiology and statistics
-
Orlando, FL, USA
-
Lachin JM. Oral presentation: update on epidemiologic research to explain the higher mortality in the intensive glycaemic control arm of the ACCORD trial. Interest group discussion on epidemiology and statistics. American Diabetes Association 70th scientific sessions. Orlando, FL, USA; 2010.
-
(2010)
American Diabetes Association 70th Scientific Sessions
-
-
Lachin, J.M.1
-
71
-
-
71049118192
-
Intensive glucoselowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis
-
Reaven PD, Moritz TE, Schwenke DC, Anderson RJ, Criqui M, Detrano R, Emanuele N, Kayshap M, Marks J, Mudaliar S, Harsha Rao R, Shah JH, Goldman S, Reda DJ, McCarren M, Abraira C, Duckworth W. Intensive glucoselowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes 2009;58:2642-2648.
-
(2009)
Diabetes
, vol.58
, pp. 2642-2648
-
-
Reaven, P.D.1
Moritz, T.E.2
Schwenke, D.C.3
Anderson, R.J.4
Criqui, M.5
Detrano, R.6
Emanuele, N.7
Kayshap, M.8
Marks, J.9
Mudaliar, S.10
Harsha Rao, R.11
Shah, J.H.12
Goldman, S.13
Reda, D.J.14
McCarren, M.15
Abraira, C.16
Duckworth, W.17
-
72
-
-
75749145810
-
Survival as a function of HbA(1c) in people with type 2 diabetes: A retrospective cohort study
-
Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study. Lancet 2010;375:481-489.
-
(2010)
Lancet
, vol.375
, pp. 481-489
-
-
Currie, C.J.1
Peters, J.R.2
Tynan, A.3
Evans, M.4
Heine, R.J.5
Bracco, O.L.6
Zagar, T.7
Poole, C.D.8
-
73
-
-
77649205993
-
Glycated haemoglobin below 7% No to QOF target of less than 7%, again
-
Lehman R, Krumholz HM. Glycated haemoglobin below 7%. No to QOF target of less than 7%, again. BMJ 2010;340:c985.
-
(2010)
BMJ
, vol.340
-
-
Lehman, R.1
Krumholz, H.M.2
-
74
-
-
77955585592
-
Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial
-
Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 2010;376:419-430.
-
(2010)
Lancet
, vol.376
, pp. 419-430
-
-
Ismail-Beigi, F.1
Craven, T.2
Banerji, M.A.3
Basile, J.4
Calles, J.5
Cohen, R.M.6
Cuddihy, R.7
Cushman, W.C.8
Genuth, S.9
Grimm Jr., R.H.10
Hamilton, B.P.11
Hoogwerf, B.12
Karl, D.13
Katz, L.14
Krikorian, A.15
O'Connor, P.16
Pop-Busui, R.17
Schubart, U.18
Simmons, D.19
Taylor, H.20
Thomas, A.21
Weiss, D.22
Hramiak, I.23
more..
-
75
-
-
77954654472
-
Effects of medical therapies on retinopathy progression in type 2 diabetes
-
Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ. Effects of medical therapies on retinopathy progression in type 2 diabetes. N Engl J Med 2010;363:233-244.
-
(2010)
N Engl J Med
, vol.363
, pp. 233-244
-
-
Chew, E.Y.1
Ambrosius, W.T.2
Davis, M.D.3
Danis, R.P.4
Gangaputra, S.5
Greven, C.M.6
Hubbard, L.7
Esser, B.A.8
Lovato, J.F.9
Perdue, L.H.10
Goff Jr., D.C.11
Cushman, W.C.12
Ginsberg, H.N.13
Elam, M.B.14
Genuth, S.15
Gerstein, H.C.16
Schubart, U.17
Fine, L.J.18
-
76
-
-
0037840242
-
MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial
-
Collins R, Armitage J, Parish S, Sleigh P, Peto R. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet 2003;361:2005-2016.
-
(2003)
Lancet
, vol.361
, pp. 2005-2016
-
-
Collins, R.1
Armitage, J.2
Parish, S.3
Sleigh, P.4
Peto, R.5
-
77
-
-
4344683381
-
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial
-
DOI 10.1016/S0140-6736(04)16895-5, PII S0140673604168955
-
Colhoun HM, Betteridge DJ, Durrington PN, Hitman GA, Neil HA, Livingstone SJ, Thomason MJ, Mackness MI, Charlton-Menys V, Fuller JH. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebocontrolled trial. Lancet 2004;364:685-696. (Pubitemid 39140624)
-
(2004)
Lancet
, vol.364
, Issue.9435
, pp. 685-696
-
-
Colhoun, H.M.1
Betteridge, D.J.2
Durrington, P.N.3
Hitman, G.A.4
Neil, H.A.W.5
Livingstone, S.J.6
Thomason, M.J.7
Mackness, M.I.8
Charlton-Menys, V.9
Fuller, J.H.10
-
78
-
-
33749015458
-
Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial
-
DOI 10.1093/eurheartj/ehl220
-
Ahmed S, Cannon CP, Murphy SA, Braunwald E. Acute coronary syndromes and diabetes: Is intensive lipid lowering beneficial? Results of the PROVE IT-TIMI 22 trial. Eur Heart J 2006;27:2323-2329. (Pubitemid 44453576)
-
(2006)
European Heart Journal
, vol.27
, Issue.19
, pp. 2323-2329
-
-
Ahmed, S.1
Cannon, C.P.2
Murphy, S.A.3
Braunwald, E.4
-
79
-
-
49249113364
-
Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease
-
Shepherd J, Kastelein JP, Bittner VA, Carmena R, Deedwania PC, Breazna A, Dobson S, Wilson DJ, Zuckerman AL, Wenger NK. Intensive lipid lowering with atorvastatin in patients with coronary artery disease, diabetes, and chronic kidney disease. Mayo Clin Proc 2008;83:870-879.
-
(2008)
Mayo Clin Proc
, vol.83
, pp. 870-879
-
-
Shepherd, J.1
Kastelein, J.P.2
Bittner, V.A.3
Carmena, R.4
Deedwania, P.C.5
Breazna, A.6
Dobson, S.7
Wilson, D.J.8
Zuckerman, A.L.9
Wenger, N.K.10
-
80
-
-
28044452217
-
Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
-
Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesaniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366:1849-1861.
-
(2005)
Lancet
, vol.366
, pp. 1849-1861
-
-
Keech, A.1
Simes, R.J.2
Barter, P.3
Best, J.4
Scott, R.5
Taskinen, M.R.6
Forder, P.7
Pillai, A.8
Davis, T.9
Glasziou, P.10
Drury, P.11
Kesaniemi, Y.A.12
Sullivan, D.13
Hunt, D.14
Colman, P.15
D'Emden, M.16
Whiting, M.17
Ehnholm, C.18
Laakso, M.19
-
81
-
-
64749095070
-
Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study
-
Scott R, O'Brien R, Fulcher G, Pardy C, D'Emden M, Tse D, Taskinen MR, Ehnholm C, Keech A. Effects of fenofibrate treatment on cardiovascular disease risk in 9,795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. Diabetes Care 2009;32:493-498.
-
(2009)
Diabetes Care
, vol.32
, pp. 493-498
-
-
Scott, R.1
O'Brien, R.2
Fulcher, G.3
Pardy, C.4
D'Emden, M.5
Tse, D.6
Taskinen, M.R.7
Ehnholm, C.8
Keech, A.9
-
82
-
-
0037049366
-
Diabetes, plasma insulin, and cardiovascular disease: Subgroup analysis from the Department of Veterans Affairs High-density Lipoprotein Intervention Trial (VA-HIT)
-
DOI 10.1001/archinte.162.22.2597
-
Rubins HB, Robins SJ, Collins D, Nelson DB, Elam MB, Schaefer EJ, Faas FH, Anderson JW. Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs High-Density Lipoprotein Intervention Trial (VA-HIT). Arch Intern Med 2002;162:2597-2604. (Pubitemid 35453499)
-
(2002)
Archives of Internal Medicine
, vol.162
, Issue.22
, pp. 2597-2604
-
-
Rubins, H.B.1
Robins, S.J.2
Collins, D.3
Nelson, D.B.4
Elam, M.B.5
Schaefer, E.J.6
Faas, F.H.7
Anderson, J.W.8
-
83
-
-
0023232216
-
Helsinki Heart Study: Primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease
-
Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V et al. Helsinki Heart Study: primaryprevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med 1987;317:1237-1245. (Pubitemid 17147964)
-
(1987)
New England Journal of Medicine
, vol.317
, Issue.20
, pp. 1237-1245
-
-
Frick, M.H.1
Elo, O.2
Haapa, K.3
-
84
-
-
0034604225
-
Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study
-
The Bezafibrate Infarction Prevention Study Group
-
The Bezafibrate Infarction Prevention Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation 2000;102:21-27.
-
(2000)
Circulation
, vol.102
, pp. 21-27
-
-
-
85
-
-
0033527030
-
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
-
DOI 10.1056/NEJM199908053410604
-
Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, Faas FH, Linares E, Schaefer EJ, Schectman G, Wilt TJ, Wittes J. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of highdensity lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N Engl J Med 1999;341:410-418. (Pubitemid 29362514)
-
(1999)
New England Journal of Medicine
, vol.341
, Issue.6
, pp. 410-418
-
-
Rubins, H.B.1
Robins, S.J.2
Collins, D.3
Fye, C.L.4
Anderson, J.W.5
Elam, M.B.6
Faas, F.H.7
Linares, E.8
Schaefer, E.J.9
Schectman, G.10
Wilt, T.J.11
Wittes, J.12
-
86
-
-
77951704587
-
Effects of combination lipid therapy in type 2 diabetes mellitus
-
Ginsberg HN, Elam MB, Lovato LC, Crouse JR III, Leiter LA, Linz P, Friedewald WT, Buse JB, Gerstein HC, Probstfield J, Grimm RH, Ismail-Beigi F, Bigger JT, Goff DC Jr, Cushman WC, Simons-Morton DG, Byington RP. Effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010; 362:1563-1574.
-
(2010)
N Engl J Med
, vol.362
, pp. 1563-1574
-
-
Ginsberg, H.N.1
Elam, M.B.2
Lovato, L.C.3
Crouse Iii, J.R.4
Leiter, L.A.5
Linz, P.6
Friedewald, W.T.7
Buse, J.B.8
Gerstein, H.C.9
Probstfield, J.10
Grimm, R.H.11
Ismail-Beigi, F.12
Bigger, J.T.13
Goff Jr., D.C.14
Cushman, W.C.15
Simons-Morton, D.G.16
Byington, R.P.17
-
87
-
-
0026597808
-
Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment
-
Manninen V, Tenkanen L, Koskinen P, Huttunen JK, Manttari M, Heinonen OP, Frick MH. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation 1992;85:37-45.
-
(1992)
Circulation
, vol.85
, pp. 37-45
-
-
Manninen, V.1
Tenkanen, L.2
Koskinen, P.3
Huttunen, J.K.4
Manttari, M.5
Heinonen, O.P.6
Frick, M.H.7
-
88
-
-
77952708442
-
Effects of fibrates on cardiovascular outcomes: A systematic review and meta-analysis
-
Jun M, Foote C, Lv J, Neal B, Patel A, Nicholls SJ, Grobbee DE, Cass A, Chalmers J, Perkovic V. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet 2010;375:1875-1884.
-
(2010)
Lancet
, vol.375
, pp. 1875-1884
-
-
Jun, M.1
Foote, C.2
Lv, J.3
Neal, B.4
Patel, A.5
Nicholls, S.J.6
Grobbee, D.E.7
Cass, A.8
Chalmers, J.9
Perkovic, V.10
-
89
-
-
77954178839
-
Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus
-
Timbie JW, Hayward RA, Vijan S. Variation in the net benefit of aggressive cardiovascular risk factor control across the US population of patients with diabetes mellitus. Arch Intern Med 2010;170:1037-1044.
-
(2010)
Arch Intern Med
, vol.170
, pp. 1037-1044
-
-
Timbie, J.W.1
Hayward, R.A.2
Vijan, S.3
-
90
-
-
0037472879
-
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
-
DOI 10.1056/NEJMoa021778
-
Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med 2003;348:383-393. (Pubitemid 36159355)
-
(2003)
New England Journal of Medicine
, vol.348
, Issue.5
, pp. 383-393
-
-
Gaede, P.1
Vedel, P.2
Larsen, N.3
Jensen, G.V.H.4
Parving, H.-H.5
Pedersen, O.6
-
91
-
-
38949210220
-
Effect of a multifactorial intervention on mortality in type 2 diabetes
-
DOI 10.1056/NEJMoa0706245
-
Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008;358:580-591. (Pubitemid 351214285)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.6
, pp. 580-591
-
-
Gaede, P.1
Lund-Andersen, H.2
Parving, H.-H.3
Pedersen, O.4
-
92
-
-
77953414555
-
Diabetes connected health: A pilot study of a patient-and provider-shared glucose monitoring web application
-
Watson AJ, Kvedar JC, Rahman B, Pelletier AC, Salber G, Grant RW. Diabetes connected health: a pilot study of a patient-and provider-shared glucose monitoring web application. J Diabetes Sci Technol 2009;3:345-352.
-
(2009)
J Diabetes Sci Technol
, vol.3
, pp. 345-352
-
-
Watson, A.J.1
Kvedar, J.C.2
Rahman, B.3
Pelletier, A.C.4
Salber, G.5
Grant, R.W.6
-
93
-
-
51649116699
-
Practice-linked online personal health records for type 2 diabetes mellitus: A randomized controlled trial
-
Grant RW, Wald JS, Schnipper JL, Gandhi TK, Poon EG, Orav EJ, Williams DH, Volk LA, Middleton B. Practice-linked online personal health records for type 2 diabetes mellitus: a randomized controlled trial. Arch Intern Med 2008;168: 1776-1782.
-
(2008)
Arch Intern Med
, vol.168
, pp. 1776-1782
-
-
Grant, R.W.1
Wald, J.S.2
Schnipper, J.L.3
Gandhi, T.K.4
Poon, E.G.5
Orav, E.J.6
Williams, D.H.7
Volk, L.A.8
Middleton, B.9
-
94
-
-
67651156329
-
Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial
-
Holbrook A, Thabane L, Keshavjee K, Dolovich L, Bernstein B, Chan D, Troyan S, Foster G, Gerstein H. Individualized electronic decision support and reminders to improve diabetes care in the community: COMPETE II randomized trial. CMAJ 2009;181:37-44.
-
(2009)
CMAJ
, vol.181
, pp. 37-44
-
-
Holbrook, A.1
Thabane, L.2
Keshavjee, K.3
Dolovich, L.4
Bernstein, B.5
Chan, D.6
Troyan, S.7
Foster, G.8
Gerstein, H.9
-
95
-
-
0032585222
-
Randomised controlled trial of patient centred care of diabetes in general practice: Impact on current wellbeing and future disease risk
-
Kinmonth AL, Woodcock A, Griffin S, Spiegal N, Campbell MJ. Randomised controlled trial of patient centred care of diabetes in general practice: impact on current wellbeing and future disease risk. The Diabetes Care From Diagnosis Research Team. BMJ 1998;317:1202-1208. (Pubitemid 28488511)
-
(1998)
British Medical Journal
, vol.317
, Issue.7167
, pp. 1202-1208
-
-
Kinmonth, A.L.1
Woodcock, A.2
Griffin, S.3
Spiegal, N.4
Campbell, M.J.5
-
96
-
-
37849010633
-
Patientprovider interaction from the perspectives of type 2 diabetes patients in Muscat, Oman: A qualitative study
-
Abdulhadi N, Al Shafaee M, Freudenthal S, Ostenson CG, Wahlstrom R. Patientprovider interaction from the perspectives of type 2 diabetes patients in Muscat, Oman: a qualitative study. BMC Health Serv Res 2007;7:162.
-
(2007)
BMC Health Serv Res
, vol.7
, pp. 162
-
-
Abdulhadi, N.1
Al Shafaee, M.2
Freudenthal, S.3
Ostenson, C.G.4
Wahlstrom, R.5
-
97
-
-
34249911988
-
A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes
-
DOI 10.2337/dc06-2260
-
Channon SJ, Huws-Thomas MV, Rollnick S, Hood K, Cannings-John RL, Rogers C, Gregory JW. A multicenter randomized controlled trial of motivational interviewing in teenagers with diabetes. Diabetes Care 2007;30:1390-1395. (Pubitemid 46871143)
-
(2007)
Diabetes Care
, vol.30
, Issue.6
, pp. 1390-1395
-
-
Channon, S.J.1
Huws-Thomas, M.V.2
Rollnick, S.3
Hood, K.4
Cannings-John, R.L.5
Rogers, C.6
Gregory, J.W.7
-
98
-
-
34250710107
-
Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: Rationale and design
-
Sullivan MD, Anderson RT, Aron D, Atkinson HH, Bastien A, Chen GJ, Feeney P, Gafni A, Hwang W, Katz LA, Narayan KM, Nwachuku C, O'Connor PJ, Zhang P. Health-related quality of life and cost-effectiveness components of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: rationale and design. Am J Cardiol 2007;99:90i-102i.
-
(2007)
Am J Cardiol
, vol.99
-
-
Sullivan, M.D.1
Anderson, R.T.2
Aron, D.3
Atkinson, H.H.4
Bastien, A.5
Chen, G.J.6
Feeney, P.7
Gafni, A.8
Hwang, W.9
Katz, L.A.10
Narayan, K.M.11
Nwachuku, C.12
O'Connor, P.J.13
Zhang, P.14
|